BibTex RIS Cite

Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı

Year 2006, Volume: 25 Issue: 1-2, 29 - 32, 01.06.2006

Handan Hilal Arslan

https://doi.org/10.30782/uluvfd.163633
Cited By: 1

Abstract

Keywords

-

References

  • ARNOTT IDR, WATTS D, SATSANGI J. Azothioprine and anti-TNFα Therapies in Chorn’s Disease: A Rewiew of Pharmacology, Clinical Efficacy and Safety. Pharmacol Res 2003; 47: 1- 10.
  • BAEZ JL, HENDRICK MJ, WALKER LM, WASHABAU ultrasonographic, and endoscopic finding in cats with inflammatory disease of stomach and small intestine: 33 cases (1990-1997). J.A.V.M.A. 1999; 215: 349-354. Radiographic,
  • CROSS RK, WILSON KT. Nitric Oxide in Inflammatory Bowel Disease. Inflamm Bowel Dis 2003; 9: 179-189.
  • DIEHL KJ. Eosinophylic Enteritis. In: Tilley ve Smith eds. The 5 Minute Veterinary Consult, Volume:1. Baltimore: Williams and Wilkins Company. 552-553, 1997.
  • ELSON CO, SARTOR RB, TENNYSON GS, RIDDELL RH. Experimental Models of Inflammatory Bowel Disease. Gastroenterology 1995; 109: 1344-1367.
  • FABIA R, AR'RAJAB A, JOHANSSON ML, ANDERSSON R, WILLEN R, JEPPSSON B, MOLIN G, BENGMARK S. Impairment of Bacterial Flora in Human Ulcerative Colitis and Experimental Colitis in the Rat. Digestion 1993; 54: 248-255.
  • FLOCH MH. Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease, Curr Treat Options. Gastroenterology 2003; 6: 283-288.
  • FOSTER JC, GLASS MD, COURTNEY PD, WARD LA. Affect of Lactobacillus and Bifidobacterium on Cryptosporidium Parvum Oocyst Viability. Food Microbiol 2002; 20: 351- 357.
  • GAON D, GARMENDIA C, MURRIELO NO, DE CUCCO GAMES A, CERCHIO A, QINTAS R, GONZALEZ SN, OLIVER G. Effect of Lactobacillus Strains (L. casei and L. acidophillus Strains cerela) on Bacterial Overgrowth-Related Chronic Diarrhea. Medicina (B. Aires) 2002; 62: 159-163.
  • GIONCHETTI P, RIZZELLO F, VENTURI A, CAMPIERI M. Probiotics in Infective Diarrhoea and Inflammatory Bowel Diseases. J Gastroen Hepatol 2000; 15: 489-493.
  • HALL EJ, TENNANT BJ, PAYNE-JOHNSON CE, KELLY DF. Boxer Colitis. The Vet Rec 1992; 130: 148.
  • HART AL, STAGG AJ, KAMM MA. Use of Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 111-119.
  • HEAD KA, JURENKA JS. Inflammatory Bowel Disease Pathophysiology and Conventional and alternative treatment options. Altern Med Rev. 2003; 8: 247- 283. Ulcerative Colitis
  • JERGENS AE, MOORE FM, HAYNES JS, MILES KG. Idiopathic Inflammatory Bowel Disease in Dogs And Cats: 84 Cases (1987-1990). J.A.V.M.A. 1992; 201: 1603-1608.
  • JERGENS AE. Inflammatory Bowel Disease. Vet Clin N Am-Small 1999; 29: 501-521
  • MIMURA T, KAMINISHI M, KAMM MA. Probiotic Therapy For Pouchitis and Its Endoscopic Findings. Dig Endosc 2002; 14: 47- 52.
  • MOORE LE, BURROWS CF. Histiyocytic Ulserative Colitis. In: Tilley and Smith, eds. The 5 Minute Veterinary Consult, Volume:1. Baltimore: Williams and Wilkins Company. 466-467, 1997.
  • PAVAN S, DESREUMAUX P, MERCEINER A. Use of Mouse Model to Evaluate The Persistence, Safety and Immune Modulation Capacities of Lactic Acid Bacteria. Clin Diagn Lab Immun 2003; 10: 696-701.
  • PIZARRO TT, ARSENEAU KO, BAMIS G, COMINELLI F. Mouse Models for the study of Crohn’s Disease. Trends Mol Med 2003; 9: 218- 222.
  • RANI B, KHETARPAUL N. Probiotic Fermented Food Mixtures: Possible Applications in Clinical Anti-Diarrhoea Usage. Nutr Health 1998; 12: 97- 105.
  • SCHOLMERICH J, HUBER G. Biological therapy in IBD. Anti-Tumor Necrosis Factor- Alpha and Others. Dig Dis. 2003; 21: 180-191.
  • SCHUMACHER J, EDWARDS JF, COHEN ND. Chronic idiopathic inflammatory bowel diseases of the horse. J Vet Intern Med 2000; 14: 258-265.
  • SHANAHAN F. Probiotics in Inflammatory Bowel Disease-Therapeutic Rationale and Role. Adv Drug Deliv Rev 2004; 56: 809-818.
  • SHIBOLET O, KARMELI F, ELIAKIM R, SWENNEN E, BRIGIDI P, GIONCHETTI P, CAMPIERI, RACHMILEWITZ D. Variable Response to Probiotics in Two Models of Experimental Colitis in Rats. Inflamm Bowel Dis. 2002; 8: 399-406.
  • STROMBECK DR, GUILFORD WG. Idiopathic Inflammatory Bowel Disease In: Strombeck and Guilford eds.; Small Animal Gastroenterology, California: Stonegate Publishing. 357-390, Chapter 21, 1990.
  • TURGUT K, OK M. Kronik Yangısal Kalın Ba- ğırsak Hastalıkları. Veteriner Gastroenteroloji. Konya: Mikro Dizgi, 354-361, 2001.
  • WOOD RD. Inflammatory Bowel Disease in Dogs And Cats. Vet Tech 1996; 17: 401-407.

Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı

Year 2006, Volume: 25 Issue: 1-2, 29 - 32, 01.06.2006

Handan Hilal Arslan

https://doi.org/10.30782/uluvfd.163633
Cited By: 1

Abstract

YBH (Yangısal Bağırsak Hastalığı), yangı hücrelerinin ince ve kalın bağırsakta lamina propriyaya infiltrasyonu ile karakterize bir grup gastrointestinal bozukluktur. YBH’nin etiyolojisi bilinmemektedir. Bununla birlikte konakçının bireysel duyarlılığı, genetik yapı ve çevre etkilerinin önemi açıktır. YBH’nin ilaç tedavisi genellikle kortikosteroid, azathioprin ve metronidazolü içermektedir. Kortikosteroidler, YBH’nin tedavisinin başlıca dayanağı olup en sık kullanılanı prednizolondur. Azathioprin, kronik steroid tedavisinin yan etkilerinin ve kortikosteroidlerin dozunun azaltılmasını sağlamak için kullanılabilen immunsupresif bir ilaçtır. Metronidazol, antibakteriyel ve antiprotozoal özelliklere sahiptir ve immunomodulatör etkisi olduğuna dair kanıtlar bulunmaktadır. Probiyotikler, ağız yoluyla alındığında bağırsağın mikrobiyel florasını düzenleyici ve tedavi edici yararlı etkileri olan non-patojenik canlı mikroorganizmalardır. Deneysel ve klinik çalışmalar, YBH’nin tedavisinde probiyotiklerin potansiyel bir tedavi edici etkinliği olduğunu göstermektedir. Ancak probiyotiklerin YBH’nin tedavisinde terapötik bir ajan olarak kesin rolünün belirlenebilmesi için çalışmalar hala sürmektedir

Keywords

Probiyotik tedavi yangısal bağırsak hastalığı

References

  • ARNOTT IDR, WATTS D, SATSANGI J. Azothioprine and anti-TNFα Therapies in Chorn’s Disease: A Rewiew of Pharmacology, Clinical Efficacy and Safety. Pharmacol Res 2003; 47: 1- 10.
  • BAEZ JL, HENDRICK MJ, WALKER LM, WASHABAU ultrasonographic, and endoscopic finding in cats with inflammatory disease of stomach and small intestine: 33 cases (1990-1997). J.A.V.M.A. 1999; 215: 349-354. Radiographic,
  • CROSS RK, WILSON KT. Nitric Oxide in Inflammatory Bowel Disease. Inflamm Bowel Dis 2003; 9: 179-189.
  • DIEHL KJ. Eosinophylic Enteritis. In: Tilley ve Smith eds. The 5 Minute Veterinary Consult, Volume:1. Baltimore: Williams and Wilkins Company. 552-553, 1997.
  • ELSON CO, SARTOR RB, TENNYSON GS, RIDDELL RH. Experimental Models of Inflammatory Bowel Disease. Gastroenterology 1995; 109: 1344-1367.
  • FABIA R, AR'RAJAB A, JOHANSSON ML, ANDERSSON R, WILLEN R, JEPPSSON B, MOLIN G, BENGMARK S. Impairment of Bacterial Flora in Human Ulcerative Colitis and Experimental Colitis in the Rat. Digestion 1993; 54: 248-255.
  • FLOCH MH. Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease, Curr Treat Options. Gastroenterology 2003; 6: 283-288.
  • FOSTER JC, GLASS MD, COURTNEY PD, WARD LA. Affect of Lactobacillus and Bifidobacterium on Cryptosporidium Parvum Oocyst Viability. Food Microbiol 2002; 20: 351- 357.
  • GAON D, GARMENDIA C, MURRIELO NO, DE CUCCO GAMES A, CERCHIO A, QINTAS R, GONZALEZ SN, OLIVER G. Effect of Lactobacillus Strains (L. casei and L. acidophillus Strains cerela) on Bacterial Overgrowth-Related Chronic Diarrhea. Medicina (B. Aires) 2002; 62: 159-163.
  • GIONCHETTI P, RIZZELLO F, VENTURI A, CAMPIERI M. Probiotics in Infective Diarrhoea and Inflammatory Bowel Diseases. J Gastroen Hepatol 2000; 15: 489-493.
  • HALL EJ, TENNANT BJ, PAYNE-JOHNSON CE, KELLY DF. Boxer Colitis. The Vet Rec 1992; 130: 148.
  • HART AL, STAGG AJ, KAMM MA. Use of Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 111-119.
  • HEAD KA, JURENKA JS. Inflammatory Bowel Disease Pathophysiology and Conventional and alternative treatment options. Altern Med Rev. 2003; 8: 247- 283. Ulcerative Colitis
  • JERGENS AE, MOORE FM, HAYNES JS, MILES KG. Idiopathic Inflammatory Bowel Disease in Dogs And Cats: 84 Cases (1987-1990). J.A.V.M.A. 1992; 201: 1603-1608.
  • JERGENS AE. Inflammatory Bowel Disease. Vet Clin N Am-Small 1999; 29: 501-521
  • MIMURA T, KAMINISHI M, KAMM MA. Probiotic Therapy For Pouchitis and Its Endoscopic Findings. Dig Endosc 2002; 14: 47- 52.
  • MOORE LE, BURROWS CF. Histiyocytic Ulserative Colitis. In: Tilley and Smith, eds. The 5 Minute Veterinary Consult, Volume:1. Baltimore: Williams and Wilkins Company. 466-467, 1997.
  • PAVAN S, DESREUMAUX P, MERCEINER A. Use of Mouse Model to Evaluate The Persistence, Safety and Immune Modulation Capacities of Lactic Acid Bacteria. Clin Diagn Lab Immun 2003; 10: 696-701.
  • PIZARRO TT, ARSENEAU KO, BAMIS G, COMINELLI F. Mouse Models for the study of Crohn’s Disease. Trends Mol Med 2003; 9: 218- 222.
  • RANI B, KHETARPAUL N. Probiotic Fermented Food Mixtures: Possible Applications in Clinical Anti-Diarrhoea Usage. Nutr Health 1998; 12: 97- 105.
  • SCHOLMERICH J, HUBER G. Biological therapy in IBD. Anti-Tumor Necrosis Factor- Alpha and Others. Dig Dis. 2003; 21: 180-191.
  • SCHUMACHER J, EDWARDS JF, COHEN ND. Chronic idiopathic inflammatory bowel diseases of the horse. J Vet Intern Med 2000; 14: 258-265.
  • SHANAHAN F. Probiotics in Inflammatory Bowel Disease-Therapeutic Rationale and Role. Adv Drug Deliv Rev 2004; 56: 809-818.
  • SHIBOLET O, KARMELI F, ELIAKIM R, SWENNEN E, BRIGIDI P, GIONCHETTI P, CAMPIERI, RACHMILEWITZ D. Variable Response to Probiotics in Two Models of Experimental Colitis in Rats. Inflamm Bowel Dis. 2002; 8: 399-406.
  • STROMBECK DR, GUILFORD WG. Idiopathic Inflammatory Bowel Disease In: Strombeck and Guilford eds.; Small Animal Gastroenterology, California: Stonegate Publishing. 357-390, Chapter 21, 1990.
  • TURGUT K, OK M. Kronik Yangısal Kalın Ba- ğırsak Hastalıkları. Veteriner Gastroenteroloji. Konya: Mikro Dizgi, 354-361, 2001.
  • WOOD RD. Inflammatory Bowel Disease in Dogs And Cats. Vet Tech 1996; 17: 401-407.
There are 27 citations in total.

Details

Primary Language Turkish
Journal Section Articles
Authors

Handan Hilal Arslan This is me

Publication Date June 1, 2006
Published in Issue Year 2006 Volume: 25 Issue: 1-2

Cite

APA Arslan, H. H. (2006). Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı. Uludağ Üniversitesi Veteriner Fakültesi Dergisi, 25(1-2), 29-32. https://doi.org/10.30782/uluvfd.163633
AMA Arslan HH. Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı. Uludağ Üniversitesi Veteriner Fakültesi Dergisi. June 2006;25(1-2):29-32. doi:10.30782/uluvfd.163633
Chicago Arslan, Handan Hilal. “Yangısal Bağırsak Hastalığı Ve Probiyotiklerle Güncel Tedavi Yaklaşımı”. Uludağ Üniversitesi Veteriner Fakültesi Dergisi 25, no. 1-2 (June 2006): 29-32. https://doi.org/10.30782/uluvfd.163633.
EndNote Arslan HH (June 1, 2006) Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı. Uludağ Üniversitesi Veteriner Fakültesi Dergisi 25 1-2 29–32.
IEEE H. H. Arslan, “Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı”, Uludağ Üniversitesi Veteriner Fakültesi Dergisi, vol. 25, no. 1-2, pp. 29–32, 2006, doi: 10.30782/uluvfd.163633.
ISNAD Arslan, Handan Hilal. “Yangısal Bağırsak Hastalığı Ve Probiyotiklerle Güncel Tedavi Yaklaşımı”. Uludağ Üniversitesi Veteriner Fakültesi Dergisi 25/1-2 (June 2006), 29-32. https://doi.org/10.30782/uluvfd.163633.
JAMA Arslan HH. Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı. Uludağ Üniversitesi Veteriner Fakültesi Dergisi. 2006;25:29–32.
MLA Arslan, Handan Hilal. “Yangısal Bağırsak Hastalığı Ve Probiyotiklerle Güncel Tedavi Yaklaşımı”. Uludağ Üniversitesi Veteriner Fakültesi Dergisi, vol. 25, no. 1-2, 2006, pp. 29-32, doi:10.30782/uluvfd.163633.
Vancouver Arslan HH. Yangısal Bağırsak Hastalığı ve Probiyotiklerle Güncel Tedavi Yaklaşımı. Uludağ Üniversitesi Veteriner Fakültesi Dergisi. 2006;25(1-2):29-32.

Cited By

Management of inflammatory bowel disease and lymphangiectasia in a dog with octreotide and tranexamic acid
Ankara Üniversitesi Veteriner Fakültesi Dergisi
https://doi.org/10.33988/auvfd.1263493